VistaGen Therapeutics

3 followers

‌

VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high unmet need.

Industries

Education, Pharmaceutical

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Shawn K. Singh

CEO & Director

Shawn K. Singh

Collapse

Chief Legal Officer

CFO

SVP, Head of CMC

SVP, Development Operations

Trisha Fitzmaurice

SVP, Human Resources

Joshua Prince

VP, Strategic Insights & Analytics

Louis Monti

VP, Translational Medicine

Ross A. Baker

VP, Global Medical Affairs

Mark Flather

VP, Investor Relations

Mark A. McPartland

VP, Corporate Development

Ester Salmán

VP, Clinical Research

Teams

Leadership Team

5 members

Clinical and Medical Team

6 members

Legal and Compliance

3 members

Project Management

3 members

Regulatory and Quality Affairs

2 members

Similar companies

Bezos Academy

3 followers

Thurgood Marshall College Fund

1 follower

JoVE (Journal of Visualized Experiments)

4 followers

eGenesis

1 follower

Financial Finesse

2 followers

Bristol-Myers Squibb

199 followers

Walgreens Boots Alliance

108 followers

Springboard Collaborative

149 followers

Pearson

64 followers

Lundbeck

34 followers

Catalent

18 followers

Explore companies